VISCOPASTE PB7 bandage is made of open woven cloth impregnated with a paste containing 10 % Zinc Oxide BP rolled onto a plastic core. It also contains Purified Water BP, Glycerol BP, Cetostearyl alcohol BP, Cetomacrogol BP, White Oil BP, Guar Gum, Xanthan Gum, Methyl p-hydroxybenzoate BP, and Propyl p-hydroxybenzoate BP. Each bandage is presented in a wrapper and sealed in a polythene bag contained in a cardboard carton. VISCOPASTE PB7 provides topical treatment. It provides a moist wound-healing environment over a leg ulcer, helps to reduce skin irritation and soothes and protects surrounding skin. It will not dry out in use.VISCOPASTE PB7 is for use as a topical treatment only. It is indicated to assist the management of venous leg ulcers. Where venous insufficiency exists, the paste bandage should be used under graduated compression bandaging. VISCOPASTE PB7 is also suitable for use in the treatment of chronic eczema/dermatitis, where occlusion is indicated. This product is ready for use upon removal from the sealed pouch and wrapper.
There are two ways that the bandage can be applied:
- Beginning at the base of the toes, the bandage should be loosely wrapped around
the foot, heel and around the leg in a spiral fashion to just below the knee. Once
applied, the bandage should then be smoothed and moulded around the leg.
- Beginning at the base of the toes, the bandage should be loosely wrapped around the foot and heel and then, whilst wrapping from the ankle, with every pleat, at the front of the leg. This should be repeated up the leg until just below the knee. Compression bandaging may follow.
Once VISCOPASTE PB7 has been applied, the leg should be covered by a bandage or dressing to prevent soiling to clothes.
VISCOPASTE PB7 should not be used in known cases of sensitivity or allergy to any of the ingredients. The skin of leg ulcer patients is easily sensitised to topical medicaments, including preservatives. Sensitisation should be suspected in patients particularly where there is deterioration of the surrounding skin. Such patients should be referred for specialist diagnosis, including patch testing. One of the functions of occlusive bandages is to increase absorption. Care should be taken, therefore, if it is decided to apply topical steroid, anaesthetic or retinoid preparations under the bandage, as their absorption may be significantly increased, leading to a shorter duration of effect with an anaesthetic product. Where venous insufficiency exists, VISCOPASTE PB7 should be used under graduated compression bandaging, after first assessing the patient to exclude arterial disease. The use of Doppler ultrasound is recommended for this purpose. Failure to detect reduced arterial flow can result in pressure necrosis, amputation, or even death. The risk of a patient having arterial as well as venous disease rises with age.
Carton of 1 bandage of 7.5 cm x 6 m. Store in a dry place (<25ºc).
||7.5cm X 6m